Single-use bioreactor technology designed for production scale.
The Bionet CT3 extends two-dimensional rocking bioreactor technology into larger-scale production, with working volumes from 30 to 150 litres. Designed for organisations seeking the flexibility and operational benefits of single-use processing at increased scale, CT3 provides a scalable platform for cell culture and other bioprocess applications while reducing dependence on traditional cleaning and sterilisation infrastructure.
Rocking single-use bioreactors are not restricted to early-stage R&D. Comparable rocking technologies are used for applications including inoculum scale-up, recombinant protein production, vaccine production and antibody manufacture, demonstrating the broader production potential of this bioreactor format. Potentially deceasing both cost, complexity and risk associated with multiple seed-train steps – Contact us for further information .
